Table 4.
Scenario analysis: nitmatrelvir–ritonavir treatment, inputs, and results
| Nitmatrelvir–ritonavir | SOC | Savings* | |
|---|---|---|---|
| Cost category | |||
| Emergency department | $0.18 | $8.22 | –$8.04 |
| Hospitalization | $77.32 | $854 | $776.77 |
| Drug costs | $0.00 | $529.00 | –$710.00 |
| ICU utilization | $406.51 | –$369.71 | $97.94 |
| Total costs | $643.30 | $1,268.82 | –$625.52 |
| Resource use | |||
| Regular admission days | 0.03 | 0.38 | −0.35 |
| ICU days | 0.04 | 0.44 | −0.40 |
| Total hospital days | 0.07 | 0.82 | 0.74 |
ICU = intensive care unit; SOC = standard of care.
*
A negative value indicates cost-additive result.